Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FPHAX vs. IXJ: which is better?

Bottom line

FPHAX vs IXJ: the short answer

FPHAX (Pharmaceuticals Portfolio) and IXJ (iShares Global Healthcare ETF) are quite different portfolios: only about 36% of their top holdings (by weight) are shared.

But IXJ is far broader, holding 124 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.

IXJ is cheaper at 0.38% vs 0.67% — a difference of $29 a year per $10,000 invested.

Over five years, FPHAX returned +12.6% a year vs +6.4% for IXJ (reporting dates differ).

Updated Nov 19, 2026

FPHAX vs IXJ side by side

FPHAXIXJ
TypeMutual fundETF
Fund familyFidelityiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.67%0.38%
Annual cost per $10k$67$38
10-yr cost on $10k (prospectus)$835$480
Max front load—None
12b-1 fee0%0%
1-yr return+30.3%+14.9%
5-yr return (annualized)+12.6%+6.4%
10-yr return (annualized)+10.0%+8.2%
Best quarter+18.5%+13.6%
Worst quarter−13.6%−11.8%
Net assets (fund)$1.5B$3.8B
Number of holdings57124
Portfolio turnover77%2%
Returns as ofApr 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFPHAXIXJDifference
2025+30.3%+14.9%+15.4%
2024+9.4%+0.6%+8.8%
2023+12.5%+3.5%+9.0%
2022+1.0%−4.7%+5.7%
2021+11.8%+19.5%−7.7%
2020+11.1%+12.5%−1.4%
2019+31.6%+23.4%+8.3%
2018+5.8%+2.9%+3.0%
2017+10.7%+20.3%−9.7%
2016−16.3%−6.2%−10.1%

Source: Fund prospectus bar charts

Holdings overlap

6 of FPHAX's top 25 holdings also appear in IXJ's top 25.

Shared top holdings
HoldingFPHAXIXJ
ELI LILLY and CO28.78%10.93%
MERCK and CO INC4.74%4.12%
Roche Holding Ag4.54%3.75%
Astrazeneca Plc4.22%3.76%
Gilead Sciences Inc3.97%2.04%
JOHNSON and JOHNSON3.77%7.04%

Source: SEC Form N-PORT

FPHAX top 10

  1. ELI LILLY and CO — 28.78%
  2. Gsk Plc — 8.17%
  3. Viatris Inc — 5.45%
  4. Ucb Sa — 5.09%
  5. MERCK and CO INC — 4.74%
  6. Roche Holding Ag — 4.54%
  7. Legend Biotech Corp — 4.53%
  8. Astrazeneca Plc — 4.22%
  9. Elanco Animal Health Inc — 4.15%
  10. Jazz Pharmaceuticals Plc — 4.09%

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

FAQ

What is the difference between FPHAX and IXJ?
FPHAX (Pharmaceuticals Portfolio) and IXJ (iShares Global Healthcare ETF) are quite different portfolios: only about 36% of their top holdings (by weight) are shared. But IXJ is far broader, holding 124 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
Which is cheaper, FPHAX or IXJ?
IXJ has the lower expense ratio (0.38%).
Should I own both FPHAX and IXJ?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.